News

HealthEquity shares fell Tuesday after the company's full-year profit and sales outlook missed analysts' estimates.

On Tuesday, CervoMed Inc. (NASDAQ:CRVO) stock is trading lower after the company revealed topline data from the RewinD-LB Phase 2b clinical trial evaluating neflamapimod for dementia with Lewy bodies (DLB). The trial did not meet statistical significance thresholds for its primary endpoint of change in the Clinical Dementia Rating Sum of Boxes (a measure of dementia severity) or any of its key secondary endpoints – change from baseline in Timed Up and Go (measures a person’s mobility, balance, a

Shares of eBay fell after analysts at Jefferies downgraded the auction site Tuesday based on slowing advertising revenue growth.

Mintable sees $2.32m trading volume 24 hours post-launch of a ERC-721ex protocol.

Goldman Sachs (GS)’ chief financial officer Denis Coleman thinks the market is underestimating major rising global risks.

(Bloomberg) -- Companies are dusting off their dealmaking playbooks as an expected loosening of regulation lifts both acquisitions and stock market debuts in the coming year, according to Wall Street advisers.Most Read from BloombergBrace for a Nationwide Shuffle of Corporate HeadquartersCloud Computing Tax Threatens Chicago’s Silicon Valley DreamA Chicago Skyscraper Cements the Legacy of a Visionary Postmodern ArchitectSan Francisco, Paris Named Best Cities for Urban TransportationDC Business L

NEW YORK (Reuters) -Super Micro Computer Chief Executive Charles Liang on Tuesday said he is confident the technology company's stock will not be delisted from the Nasdaq. On the sidelines of the Reuters NEXT conference in New York, Liang said Super Micro would file its necessary financial reports by February. The embattled company received a letter last week from Nasdaq that gave it a deadline of Feb. 25 to file its delayed annual and quarterly reports, in an exception to the stock exchange's rules.